SUBOXONE | Health Canada | Drug Product Database | DPD | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
CDMO Prospector
- Demo Dashboard
Drugs in Dev.
News
Blog
Market Place
Login

SUBOXONE
Canada

PharmaCompass Sponsored Ads

Contact Supplier

Noramco Buprenorphine Hydrochloride

Contact Supplier

Buprenorphine Hydrochloride

Contact Supplier

Inke S.A: APIs manufacturing plant.

Contact Supplier

SCI PHARMTECH Buprenorphine Hydrochloride

Contact Supplier

Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

Contact Supplier

SUBOXONE

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

51 API Suppliers, 21 USDMF, 17 CEP/COS, 2 JDMF, 4 EU WC, 26 NDC API, 21 Listed Suppliers, $ API Reference Price

51 API Suppliers
21 USDMF
17 CEP/COS
2 JDMF
4 EU WC
26 NDC API
21 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

26 Drugs in Development

26 Drugs in Development

INTERMEDIATES

6 Intermediate Suppliers

6 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

254 FDF Dossiers, 95 FDA Orange Book, 114 Europe, 23 Canada, 4 South Africa, 18 Listed Dossiers

254 FDF Dossiers
95 FDA Orange Book
114 Europe
23 Canada
4 South Africa
18 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

INJECTABLE;INJECTION - EQ 0.3MG BASE/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, IMPLANT;IMPLANTATION - EQ 80MG BASE/IMPLANT, FILM;BUCCAL - EQ 2.1MG BASE;EQ 0.3MG BASE, FILM;BUCCAL - EQ 4.2MG BASE;EQ 0.7MG BASE, FILM;BUCCAL - EQ 6.3MG BASE;EQ 1MG BASE, TABLET;SUBLINGUAL - EQ 2MG BASE;EQ 0.5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;SUBLINGUAL - EQ 8MG BASE;EQ 2MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, FILM;BUCCAL - EQ 0.075MG BASE, FILM;BUCCAL - EQ 0.15MG BASE, FILM;BUCCAL - EQ 0.3MG BASE, FILM;BUCCAL - EQ 0.45MG BASE, FILM;BUCCAL - EQ 0.6MG BASE, FILM;BUCCAL - EQ 0.75MG BASE, FILM;BUCCAL - EQ 0.9MG BASE, FILM;BUCCAL, SUBLINGUAL - EQ 12MG BASE;EQ 3MG BASE, FILM;BUCCAL, SUBLINGUAL - EQ 2MG BASE;EQ 0.5MG BASE, FILM;BUCCAL, SUBLINGUAL - EQ 4MG BASE;EQ 1MG BASE, FILM;BUCCAL, SUBLINGUAL - EQ 8MG BASE;EQ 2MG BASE

INJECTABLE;INJECTION - EQ 0.3MG BASE/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
IMPLANT;IMPLANTATION - EQ 80MG BASE/IMPLANT
FILM;BUCCAL - EQ 2.1MG BASE;EQ 0.3MG BASE
FILM;BUCCAL - EQ 4.2MG BASE;EQ 0.7MG BASE
FILM;BUCCAL - EQ 6.3MG BASE;EQ 1MG BASE
TABLET;SUBLINGUAL - EQ 2MG BASE;EQ 0.5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;SUBLINGUAL - EQ 8MG BASE;EQ 2MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
FILM;BUCCAL - EQ 0.075MG BASE
FILM;BUCCAL - EQ 0.15MG BASE
FILM;BUCCAL - EQ 0.3MG BASE
FILM;BUCCAL - EQ 0.45MG BASE
FILM;BUCCAL - EQ 0.6MG BASE
FILM;BUCCAL - EQ 0.75MG BASE
FILM;BUCCAL - EQ 0.9MG BASE
FILM;BUCCAL, SUBLINGUAL - EQ 12MG BASE;EQ 3MG BASE
FILM;BUCCAL, SUBLINGUAL - EQ 2MG BASE;EQ 0.5MG BASE
FILM;BUCCAL, SUBLINGUAL - EQ 4MG BASE;EQ 1MG BASE
FILM;BUCCAL, SUBLINGUAL - EQ 8MG BASE;EQ 2MG BASE

RELATED EXCIPIENT COMPANIES

1 Minakem, 6 Rochem International Inc, 18 SPI Pharma, 8 DKSH, 1 Pharm-RX Chemical, 8 Boai NKY Pharmaceuticals Ltd, 8 Gangwal Healthcare, 3 Nanjing Well Pharmaceutical, 2 Shanghai Minbiotech, 2 Pfanstiehl, 6 Kirsch Pharma, 1 ACG Worldwide, 11 Actylis, 1 Alcedo Pharmachem, 8 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 3 Ashland, 23 BASF, 1 Bioplus Life Sciences, 1 CD Formulation, 10 Corel Pharma Chem, 6 DFE Pharma, 1 Esteem Industries, 3 Finar, 8 Gangwal Chemicals, 4 Ideal Cures, 4 Ingredion Pharma Solutions, 24 Kerry, 3 Keval Exports, 4 Kima Chemical, 6 Lonza Capsugel, 1 Lubrizol Life Science Health, 19 Microlex e.U, 2 Nippon Fine Chemical, 3 Nitika Pharmaceutical Specialities, 2 Nomisma Healthcare, 3 Novo Excipients, 4 Pharmatrans-Sanaq, 8 Pluviaendo, 3 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 26 Roquette, 7 Seppic, 7 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 9 Sigachi Industries, 3 Silverline Chemicals, 1 Symrise, 3 The Dow Chemical Company, 2 Ulanqab Kema New Material, 1 Valens Pharmachem, 3 Vasa Pharmachem, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

76 Fillers, Diluents & Binders, 46 Coating Systems & Additives, 41 Direct Compression, 40 Thickeners and Stabilizers, 36 Disintegrants & Superdisintegrants, 31 Granulation, 29 Taste Masking, 24 Controlled & Modified Release, 23 Solubilizers, 22 Chewable & Orodispersible Aids, 18 Parenteral, 17 Lubricants & Glidants, 15 Topical, 15 Co-Processed Excipients, 12 Film Formers & Plasticizers, 9 Rheology Modifiers, 7 Emulsifying Agents, 5 API Stability Enhancers, 5 Empty Capsules, 4 Coloring Agents, 4 Vegetarian Capsules, 1 Surfactant & Foaming Agents

76 Fillers, Diluents & Binders
46 Coating Systems & Additives
41 Direct Compression
40 Thickeners and Stabilizers
36 Disintegrants & Superdisintegrants
31 Granulation
29 Taste Masking
24 Controlled & Modified Release
23 Solubilizers
22 Chewable & Orodispersible Aids
18 Parenteral
17 Lubricants & Glidants
15 Topical
15 Co-Processed Excipients
12 Film Formers & Plasticizers
9 Rheology Modifiers
7 Emulsifying Agents
5 API Stability Enhancers
5 Empty Capsules
4 Coloring Agents
4 Vegetarian Capsules
1 Surfactant & Foaming Agents

DIGITAL CONTENT

1 Data Compilation #PharmaFlow, 54 News #PharmaBuzz

1 Data Compilation #PharmaFlow
54 News #PharmaBuzz

GLOBAL SALES INFORMATION

27 US Medicaid Prescriptions, 8 Regulatory FDF Prices

27 US Medicaid Prescriptions
8 Regulatory FDF Prices

MARKET PLACE

9 APIs, 4 FDF Dossiers

9 APIs
4 FDF Dossiers

PATENTS & EXCLUSIVITIES

97 US Patents, 23 Health Canada Patents

97 US Patents
23 Health Canada Patents

REF. STANDARDS & IMPURITIES

2 EDQM, 4 Others

2 EDQM
4 Others

$ API Ref.Price (USD/KG) : 21,193 Xls

Filters

Reset all filters

Filters

FILTER :

filter Applicant Reset all filters

23 All

01 1CEVA ANIMAL HEALTH INC

02 1CHAMPION ALSTOE ANIMAL HEALTH INC.

03 12INDIVIOR UK LIMITED

04 4PHARMASCIENCE INC

05 4TEVA CANADA LIMITED

06 1VETVIVA RICHTER GMBH

filter Active Ingredients Reset all filters

23 All

01 15BUPRENORPHINE (BUPRENORPHINE HYDROCHLORIDE)

02 8NALOXONE (NALOXONE HYDROCHLORIDE DIHYDRATE)

filter Dosage Form Reset all filters

23 All

01 4FILM, SOLUBLE

02 3SOLUTION

03 16TABLET

filter Brand Name Reset all filters

23 All

01 1BUPAQ

02 1BUPRENOL

03 4PMS-BUPRENORPHINE-NALOXONE

04 12SUBOXONE

05 4TEVA-BUPRENORPHINE/NALOXONE

06 1VETERGESIC MULTIDOSE

Buprenorphine Hydrochloride

List of Suppliers

Product Main Page

01

CEVA ANIMAL HEALTH INC

Aus. Peptide Conference

Not Confirmed

CEVA ANIMAL HEALTH INC

Aus. Peptide Conference

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : NARCOTICS (CDSA I)

Registration Country : Canada

BUPRENORPHINE (BUPRENORPHINE HYDROCHLORIDE)

Brand Name : VETERGESIC MULTIDOSE

Dosage Form : SOLUTION

Dosage Strength : 0.3MG/ML

Packaging : 10ML

Approval Date :

Application Number : 2342510

Regulatory Info : NARCOTICS (CDSA I)

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

INDIVIOR UK LIMITED

Aus. Peptide Conference

Not Confirmed

INDIVIOR UK LIMITED

Aus. Peptide Conference

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : NARCOTICS (CDSA I)

Registration Country : Canada

NALOXONE (NALOXONE HYDROCHLORIDE DIHYDRATE)

Brand Name : SUBOXONE

Dosage Form : TABLET

Dosage Strength : 0.5MG

Packaging : Jul-28

Approval Date :

Application Number : 2295695

Regulatory Info : NARCOTICS (CDSA I)

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

INDIVIOR UK LIMITED

Aus. Peptide Conference

Not Confirmed

INDIVIOR UK LIMITED

Aus. Peptide Conference

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : NARCOTICS (CDSA I)

Registration Country : Canada

BUPRENORPHINE (BUPRENORPHINE HYDROCHLORIDE)

Brand Name : SUBOXONE

Dosage Form : TABLET

Dosage Strength : 2MG

Packaging : Jul-28

Approval Date :

Application Number : 2295695

Regulatory Info : NARCOTICS (CDSA I)

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

04

INDIVIOR UK LIMITED

Aus. Peptide Conference

Not Confirmed

INDIVIOR UK LIMITED

Aus. Peptide Conference

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : NARCOTICS (CDSA I)

Registration Country : Canada

BUPRENORPHINE (BUPRENORPHINE HYDROCHLORIDE)

Brand Name : SUBOXONE

Dosage Form : TABLET

Dosage Strength : 8MG

Packaging : Jul-28

Approval Date :

Application Number : 2295709

Regulatory Info : NARCOTICS (CDSA I)

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

05

INDIVIOR UK LIMITED

Aus. Peptide Conference

Not Confirmed

INDIVIOR UK LIMITED

Aus. Peptide Conference

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : NARCOTICS (CDSA I)

Registration Country : Canada

NALOXONE (NALOXONE HYDROCHLORIDE DIHYDRATE)

Brand Name : SUBOXONE

Dosage Form : TABLET

Dosage Strength : 2MG

Packaging : Jul-28

Approval Date :

Application Number : 2295709

Regulatory Info : NARCOTICS (CDSA I)

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

06

PHARMASCIENCE INC

Aus. Peptide Conference

Not Confirmed

PHARMASCIENCE INC

Aus. Peptide Conference

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : NARCOTICS (CDSA I)

Registration Country : Canada

NALOXONE (NALOXONE HYDROCHLORIDE DIHYDRATE)

Brand Name : PMS-BUPRENORPHINE-NALOXONE

Dosage Form : TABLET

Dosage Strength : 0.5MG

Packaging : 30

Approval Date :

Application Number : 2424851

Regulatory Info : NARCOTICS (CDSA I)

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

07

PHARMASCIENCE INC

Aus. Peptide Conference

Not Confirmed

PHARMASCIENCE INC

Aus. Peptide Conference

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : NARCOTICS (CDSA I)

Registration Country : Canada

BUPRENORPHINE (BUPRENORPHINE HYDROCHLORIDE)

Brand Name : PMS-BUPRENORPHINE-NALOXONE

Dosage Form : TABLET

Dosage Strength : 2MG

Packaging : 30

Approval Date :

Application Number : 2424851

Regulatory Info : NARCOTICS (CDSA I)

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

08

PHARMASCIENCE INC

Aus. Peptide Conference

Not Confirmed

PHARMASCIENCE INC

Aus. Peptide Conference

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : NARCOTICS (CDSA I)

Registration Country : Canada

BUPRENORPHINE (BUPRENORPHINE HYDROCHLORIDE)

Brand Name : PMS-BUPRENORPHINE-NALOXONE

Dosage Form : TABLET

Dosage Strength : 8MG

Packaging : 30

Approval Date :

Application Number : 2424878

Regulatory Info : NARCOTICS (CDSA I)

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

09

PHARMASCIENCE INC

Aus. Peptide Conference

Not Confirmed

PHARMASCIENCE INC

Aus. Peptide Conference

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : NARCOTICS (CDSA I)

Registration Country : Canada

NALOXONE (NALOXONE HYDROCHLORIDE DIHYDRATE)

Brand Name : PMS-BUPRENORPHINE-NALOXONE

Dosage Form : TABLET

Dosage Strength : 2MG

Packaging : 30

Approval Date :

Application Number : 2424878

Regulatory Info : NARCOTICS (CDSA I)

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

10

TEVA CANADA LIMITED

Aus. Peptide Conference

Not Confirmed

TEVA CANADA LIMITED

Aus. Peptide Conference

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : NARCOTICS (CDSA I)

Registration Country : Canada

NALOXONE (NALOXONE HYDROCHLORIDE DIHYDRATE)

Brand Name : TEVA-BUPRENORPHINE/NALOXONE

Dosage Form : TABLET

Dosage Strength : 0.5MG

Packaging : 30

Approval Date :

Application Number : 2453908

Regulatory Info : NARCOTICS (CDSA I)

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

1
2
3

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Ask Us!